Search
Search Results
-
Applicability of obesity clinical practice guidelines in low- and middle-income countries
1108PDF: 562Appendix: 141HTML: 17 -
The Global Implementation Guidelines Initiative: how to optimize cardio-renal-metabolic care worldwide
3361PDF: 528Appendix: 388HTML: 26 -
iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025 - Focus on prevention and treatment of cardiometabolic disease
1054PDF: 28Supplementary: 316Appendix: 262 -
Lipoprotein(a): what clinicians need to know
310PDF: 660HTML: 23 -
iCARDIO Alliance Global Implementation Guidelines on Heart Failure 2025
11908PDF: 7860Appendix: 1044 -
Draft Document for Public Consultation: iCARDIO Alliance Global Implementation Guidelines on Heart Failure 2025
4873iCardio Guidelines: 867Comment form - closed: 142 -
Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients
1918PDF: 518SUPPLEMENTARY MATERIAL: 300GRAPHICAL ABSTRACT: 265HTML: 26 -
The association of iron deficiency with right ventricular dysfunction in Africans with heart failure
2299PDF: 390Appendix B: 436Appendix A: 318HTML: 2 -
Is the obesity paradox present in left ventricular assist device recipients? A BMI-based analysis
175PDF: 225Supplementary: 147HTML: 21 -
Sex-based differences in characteristics, management, and outcomes in heart failure with reduced ejection fraction
763PDF: 212Supplementary: 142Appendix: 111HTML: 32 -
Sex differences in clinical characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction
775PDF: 190Supplementary: 151Appendix: 105HTML: 36 -
Evolving targets for heart failure: the journey so far
2025pdf: 322HTML: 4 -
-
Safety and efficacy of left atrial appendage closure in cancer versus non-cancer patients: a systematic review and meta-analysis
1111PDF: 259Supplementary: 157HTML: 89 -
The effect of SGLT2 inhibitors on health status in patients with heart failure: a systematic review and meta-analysis
2475PDF: 656Conflict of interest: 320SUPPLEMENTARY MATERIAL: 256HTML: 61 -
SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials
1108pdf: 243Supplementary Material: 39HTML: 120 -
Modulation of cardiac metabolism in heart failure
2341PDF: 1146HTML: 26

